Unit 15, 4th Floor, No. 47, South Khordmand St., Tehran, Iran. |
+98 21 88309291, 88825946, 88311666
Actobiochem, a distinguished subsidiary of Actover Holding, not only participated in the International Pharmex Exhibition but also proudly received a prestigious award for its outstanding contributions to the pharmaceutical industry. This recognition highlights the company’s innovative advancements in the production of Active Pharmaceutical Ingredients (API) and its commitment to excellence.
The award acknowledges Actobiochem’s achievements in developing high-quality APIs in therapeutic areas such as cardiovascular, diabetes, oncology, and hormonal medications. The company’s cutting-edge technology and dedication to international standards have positioned it as a leader in Iran’s pharmaceutical sector.
ceremony, Actobiochem’s management stated:
During the award "Receiving this award is a testament to the hard work and innovation of our talented team. We are proud to represent Iran on a global stage and remain committed to enhancing the quality of pharmaceutical products and expanding our presence in international markets."
Actobiochem, a leading player in Iran’s pharmaceutical industry, organized a specialized panel on “Pharmaceutical and Medical Bioterrorism” in collaboration with health sector professionals during the Iran Health International Exhibition 2023. The event, held on May 20, 2023, aimed to address the threats posed by bioterrorism in the pharmaceutical and medical sectors and to explore the […]
Actobiochem, a prominent subsidiary of Actover Holding, proudly participated in the International Pharmex Exhibition, one of the most significant global events in the pharmaceutical industry. This exhibition provided a unique platform to showcase advancements and innovations in Active Pharmaceutical Ingredient (API) production. Actobiochem presented its diverse range of products in key therapeutic areas such as […]
Actobiochem, a subsidiary of Actover Holding, was established to produce Active Pharmaceutical Ingredients (API) and has succeeded in driving advancements in Iran’s pharmaceutical industry.
All rights reserved by Actobiochem Pharmaceutical Compony.
Leave a Reply